Please login to bookmark Close
Tech companies will be held responsible for harmful disinformation and misinformation on their platforms under new laws that will be introduced in the second half of the year.
No more jail time for ex-Kleenmaid director labelled ‘a man of greed’ by judge
Please login to bookmark Close
The founder of whitegoods distributor Kleenmaid, who won a retrial after being sentenced to nine years for fraud and insolvent trading, will not spend any more time in jail after being resentenced by a judge who called him “a man of greed”.
Clifford Chance snags Corrs litigation partner for Perth office
Please login to bookmark Close
Global firm Clifford Chance has lured a Corrs Chambers Westgarth litigation partner to meet the increased demand for projects expertise stemming from pandemic-related construction disputes.
Judge pans ‘inappropriate’ class action reforms, says courts have it covered
Please login to bookmark Close
A Federal Court judge has criticised “inappropriate” class action reforms pushed by the government, saying the courts have done a “good job” of crafting solutions to deal with issues that arise in the class action regime.
Shadow AG watched ‘in horror’ as class action reforms advanced
Please login to bookmark Close
Shadow attorney-general Mark Dreyfus said he watched “in horror” as a bill mandating that funded class actions be registered as managed investment schemes passed through Parliament in 2020 without consultation.
ASIC seeks recusal of former Freehills lawyer in costs spat with ex-Tennis Australia boss
Please login to bookmark Close
ASIC has asked a Federal Court registrar who previously worked at Herbert Smith Freehills to step down from overseeing remaining costs disputes in its failed case against former Tennis Australia president Steven Healy, who is represented by the Big Six firm.
Full Court deals drug companies a blow on patent term extensions
Please login to bookmark Close
The Full Court has upheld two judgments that shortened patent term extensions granted to Merck Sharpe & Dohme and Ono Pharmaceuticals, finding the extension regime cannot be construed as achieving a “commercial outcome for a patentee”.
Judge tosses Novartis experts out of ‘hot tub’ in MS drug patent dispute
Please login to bookmark Close
A judge has slammed Novartis for putting forward four “overlapping” experts in a dispute with Pharmacor over patents for its MS drug Gilenya and thrown three of those experts out of an upcoming joint conferral, known as a “hot tub”.
ACCC takes Facebook owner to court over scam celebrity cryptocurrency ads
Please login to bookmark Close
The consumer regulator has initiated court proceedings alleging Facebook technology allowed scam cryptocurrency ads featuring celebrities to target susceptible users and that the social media giant failed to take adequate steps to remove them.
In-N-Out Burgers settles trade mark suit against ‘ghost kitchen’ operator
Please login to bookmark Close
American fast food chain In-N-Out Burgers has settled a trade mark dispute with a Queensland fast food business that operates “ghost kitchens” under the name In & Out Aussie Burgers.